首页> 外国专利> THERAPEUTIC AGENT FOR TREATMENT OF CANCER COMPRISING HUMAN APOLIPOPROTEIN (A) KRINGLES LK68 OR LK8 GENES AS EFFECTIVE INGREDIENT, AND METHOD FOR TREATING CANCER USING THE SAME

THERAPEUTIC AGENT FOR TREATMENT OF CANCER COMPRISING HUMAN APOLIPOPROTEIN (A) KRINGLES LK68 OR LK8 GENES AS EFFECTIVE INGREDIENT, AND METHOD FOR TREATING CANCER USING THE SAME

机译:用于治疗包含人类载脂蛋白的癌症的治疗剂(A)作为有效成分的Kringles LK68或LK8基因,以及使用该治疗剂治疗癌症的方法

摘要

The present invention relates to an anticancer or an anti-metastatic agent for gene therapy, more precisely, an anticancer or an anti-metastatic agent for gene therapy containing a gene carrier or cells harboring human apolipoprotein (a) kringle KIV9-KIV10-KV (LK68) or KV (LK8) gene as an effective ingredient, and a treatment method for cancer using the same. The agent for gene therapy of the present invention has an inhibiting effect on the growth and the metastasis of a tumor, so it can be effectively used for the prevention and the treatment of various solid tumors as a metastasis inhibitor or a therapeutic agent for primary tumors.
机译:本发明涉及一种用于基因治疗的抗癌或抗转移剂,更确切地说,涉及一种基因治疗用的抗癌或抗转移剂,其包含携带人​​载脂蛋白的基因载体或细胞(a)kringle KIV9-KIV10-KV( LK68)或KV(LK8)基因作为有效成分,以及使用该基因的癌症治疗方法。本发明的基因治疗剂对肿瘤的生长和转移具有抑制作用,因此可以作为转移抑制剂或原发肿瘤的治疗剂有效地用于各种实体瘤的预防和治疗。 。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号